๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

(-)6-n-Propylnicotine Antagonizes the Antinociceptive Effects of (-)Nicotine.

โœ Scribed by Malgorzata Dukat; Mohamed El-Zahabi; Giovanni Ferretti; M. Imad Damaj; Billy R. Martin; Richard Young; Richard A. Glennon

Publisher
John Wiley and Sons
Year
2003
Weight
53 KB
Volume
34
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Antinociceptive effects of central and s
Antinociceptive effects of central and systemic administrations of nicotine in the rat
โœ Tony L. Sahley; Gary G. Berntson ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› Springer ๐ŸŒ English โš– 515 KB

Nicotine (0.16--0.50 mg/kg, SC) was found to exert a potent antinociceptive action on thermal stimuli as measured by the tail-flick test. This antinociceptive action of nicotine could be blocked by centrally active nicotinic or muscarinic blockers implicating both classes of cholinergic receptors in

Antagonism by antimuscarinic and ganglio
Antagonism by antimuscarinic and ganglion-blocking drugs of some of the behavioural effects of nicotine
โœ Cathleen F. Morrison; J. M. Goodyear; C. M. Sellers ๐Ÿ“‚ Article ๐Ÿ“… 1969 ๐Ÿ› Springer ๐ŸŒ English โš– 504 KB

The effects of nicotine on bar-pressing behaviour in the rat are blocked by meeamylamine. The depressant phase of the effect is blocked by atropine, supporting the conclusion that this depression is mediated by released acetylcholine. The quaternary compounds chlorisondamine and atropine methylnitra

Stereoselective behavioral effects of N6
Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine
โœ Steven R. Goldberg; Josรฉ A. Prada; Jonathan L. Katz ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 663 KB

Effects of the (-)- and (+)-isomers of N6-(phenylisopropyl)-adenosine (PIA) were studied in rats trained to respond under fixed-interval and fixed-ratio schedules of food reinforcement. Both isomers of PIA decreased response rates; however, the (-)-isomer decreased response rates at doses as low as